Arcellx Company Insiders

ACLX Stock  USD 65.20  1.60  2.52%   
Arcellx employs about 163 people. The company is managed by 12 executives with a total tenure of roughly 381 years, averaging almost 31.0 years of service per executive, having 13.58 employees per reported executive. Break down of Arcellx's management performance can provide insight into the company performance.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcellx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
For more information on how to buy Arcellx Stock please use our How to Invest in Arcellx guide.

Arcellx Management Team Effectiveness

The company has return on total asset (ROA) of (0.2134) % which means that it has lost $0.2134 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4718) %, meaning that it created substantial loss on money invested by shareholders. Arcellx's management efficiency ratios could be used to measure how well Arcellx manages its routine affairs as well as how well it operates its assets and liabilities.
The majority of Arcellx outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Arcellx to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Arcellx. Please pay attention to any change in the institutional holdings of Arcellx as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Arcellx in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Arcellx, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Arcellx Workforce Comparison

Arcellx is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 4,388. Arcellx holds roughly 163 in number of employees claiming about 4% of equities under Health Care industry.

Arcellx Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Arcellx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Arcellx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Arcellx insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Arcellx Notable Stakeholders

An Arcellx stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Arcellx often face trade-offs trying to please all of them. Arcellx's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Arcellx's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael MBAChief OfficerProfile
Aileen FernandesChief OfficerProfile
Kate AikenChief OfficerProfile
Michelle GilsonChief OfficerProfile
Myesha LacyChief OfficerProfile
Christopher MDChief OfficerProfile
MS JDGeneral CounselProfile
Heba NowyhedChief OfficerProfile
Narinderjeet MSChief OfficerProfile
David TiceChief OfficerProfile
Neeraj TeotiaChief OfficerProfile
Rami ElghandourCEO ChairmanProfile
String symbol = request.getParameter("s");

About Arcellx Management Performance

The success or failure of an entity such as Arcellx often depends on how effective the management is. Arcellx management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Arcellx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Arcellx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland. Arcellx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 78 people.
Please note, the imprecision that can be found in Arcellx's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Arcellx. Check Arcellx's Beneish M Score to see the likelihood of Arcellx's management manipulating its earnings.

Arcellx Workforce Analysis

Traditionally, organizations such as Arcellx use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Arcellx within its industry.

Arcellx Manpower Efficiency

Return on Arcellx Manpower

Revenue Per Employee662.2K
Revenue Per Executive9M
Net Loss Per Employee658.6K
Net Loss Per Executive8.9M
Working Capital Per Employee2.9M
Working Capital Per Executive39.5M

Additional Tools for Arcellx Stock Analysis

When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.